Term Gallery logo

Significados de t-705 em inglês

russo
арепливир
português
favipiravir
espanhol
favipiravir
catalão
favipiravir

Experimental antiviral drug with potential activity against RNA viruses.

        Termos relacionados
        favipiravir
        Sinônimos
        Examples for "favipiravir"
        Examples for "favipiravir"
        1
        FabiFlu's price is significantly lower than versions of favipiravir in other countries, the company added.
        Reuters
        2
        The first results for brincidofovir are expected in February and for favipiravir in late March.
        Reuters
        3
        T-705 (favipiravir) is a new antiviral agent in advanced clinical development for influenza therapy.
        Pubmed
        4
        These unique anti-viral profiles will make favipiravir a potentially promising drug for specifically untreatable RNA viral infections.
        Pubmed
        5
        The antiviral favipiravir from Japan's Toyama Chemical was developed to fight RNA viruses such as the new coronavirus.
        Reuters
        Uso de t-705 em inglês
        1
        In contrast, T-705 acts as a potent and GTP-competitive inhibitor of the viral polymerase.
        Pubmed
        2
        T-705 (favipiravir) is a new antiviral agent in advanced clinical development for influenza therapy.
        Pubmed
        3
        Influenza virus-infected cell cultures were exposed to T-705 or ribavirin during single or serial virus passaging.
        Pubmed
        4
        This mutagenic effect is 2-fold higher for T-705 than for ribavirin.
        Pubmed
        5
        Whereas neuraminidase inhibitors slow down viral replication, T-705 is a viral RNA polymerase inhibitor which prevents viral replication.
        Reuters
        6
        These mechanisms were also proposed for ribavirin, an established and broad antiviral drug that shares structural similarity with T-705.
        Pubmed
        7
        We here performed a comparative analysis of the effects of T-705 and ribavirin on influenza virus and host cell functions.
        Pubmed
        8
        T-705 is also currently in phase I trials in Japan where it has been put on the Health Ministry's priority list for development.
        Reuters
        9
        Survival and virological characteristics were observed for 85 patients in the control group and 39 in the T-705 treatment group.
        Pubmed